Essential Pharma and AcedrA Biopharmaceuticals sign Distribution Agreement to commercialize essential medicines in the Middle East and North Africa region
March 26, 2024 08:21 ET
|
AcedrA BioPharmaceuticals
AcedrA will commercialize 36 essential medicines in the 12 countries within the Middle East and North Africa region
TaiMed Biologics and AcedrA BioPharmaceuticals Partner to Commercialize Trogarzo® (Ibalizumab-uiyk) in the Middle East and North Africa Region
March 18, 2024 12:19 ET
|
AcedrA BioPharmaceuticals; TaiMed Biologics
TaiMed and AcedrA officially signed an exclusive license, commercialization, and distribution agreement for Trogarzo in the MENA region.